PRKDC expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.96873636784767E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.85170048370298E-10 |
Normal-vs-Stage2 |
2.56619999694507E-08 |
Normal-vs-Stage3 |
1.83310000512193E-09 |
Normal-vs-Stage4 |
1.176890E-04 |
Stage1-vs-Stage2 |
4.072800E-01 |
Stage1-vs-Stage3 |
2.886400E-01 |
Stage1-vs-Stage4 |
6.960000E-01 |
Stage2-vs-Stage3 |
8.917600E-01 |
Stage2-vs-Stage4 |
4.039400E-01 |
Stage3-vs-Stage4 |
3.348200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.58002557890813E-12 |
Normal-vs-AfricanAmerican |
6.00739999967459E-08 |
Normal-vs-Asian |
8.952200E-02 |
Caucasian-vs-AfricanAmerican |
6.027400E-01 |
Caucasian-vs-Asian |
5.396000E-01 |
AfricanAmerican-vs-Asian |
4.149400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.03329567124888E-11 |
Normal-vs-Female |
1.28529997756033E-09 |
Male-vs-Female |
2.843800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.829000E-04 |
Normal-vs-Age(41-60Yrs) |
6.64719945753234E-10 |
Normal-vs-Age(61-80Yrs) |
7.2706951570467E-11 |
Normal-vs-Age(81-100Yrs) |
5.58909999948121E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.924800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.211000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.086000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.212400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.125980E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.657550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.643800E-02 |
Normal-vs-Grade 2 |
4.05497857514092E-12 |
Normal-vs-Grade 3 |
1.63569158218024E-12 |
Normal-vs-Grade 4 |
7.003300E-04 |
Grade 1-vs-Grade 2 |
1.305420E-01 |
Grade 1-vs-Grade 3 |
4.115500E-02 |
Grade 1-vs-Grade 4 |
3.490800E-01 |
Grade 2-vs-Grade 3 |
1.477190E-01 |
Grade 2-vs-Grade 4 |
6.238800E-01 |
Grade 3-vs-Grade 4 |
2.759200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.921699466223E-10 |
Normal-vs-ccB subtype |
1.0270000000423E-06 |
ccA subtype-vs-ccB subtype |
1.904600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.41329964292925E-10 |
Normal-vs-N1 |
3.884800E-01 |
N0-vs-N1 |
2.544800E-01 |
|
|